Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

被引:0
|
作者
M. Petrillo
P. De Iaco
S. Cianci
M. Perrone
B. Costantini
C. Ronsini
G. Scambia
A. Fagotti
机构
[1] Catholic University of the Sacred Heart,Department of Obstetrics and Gynecology
[2] University of Bologna,Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, S. Orsola Hospital
[3] University of Perugia,Division of Minimally Invasive Gynecological Surgery, St. Maria Hospital
来源
关键词
Peritoneal Cancer Index; Hyperthermic Intraperitoneal Chemotherapy; Memorial Sloan Kettering Cancer Center; Optimal Cytoreduction; Interval Debulking Surgery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1660 / 1665
页数:5
相关论文
共 50 条
  • [41] Robotic and open cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of recurrent ovarian carcinoma
    Schroeder, E.
    Diaz, J.
    Kreafle, J.
    Angel, K.
    Estape, R.
    Estape, R.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 436 - 436
  • [42] Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer
    Felsinger, Michal
    Minar, Lubos
    Weinberger, Vit
    Rovny, Ivo
    Zlamal, Filip
    Bienertova-Vasku, Julie
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 228 : 154 - 160
  • [43] Recurrent Peritoneal Metastases after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer
    Koenigsrainer, I.
    Struller, F.
    Zieker, D.
    Koenigsrainer, A.
    Beckert, S.
    ZENTRALBLATT FUR CHIRURGIE, 2015, 140 (06): : 607 - 609
  • [44] Quality of Life in Platinum-Sensitive Recurrent Ovarian Cancer: Chemotherapy Versus Surgery Plus Chemotherapy
    Plotti, Francesco
    Scaletta, Giuseppe
    Aloisi, Alessia
    Luvero, Daniela
    Capriglione, Stella
    Miranda, Andrea
    Montera, Roberto
    Nardone, Carlo De Cicco
    Terranova, Corrado
    Angioli, Roberto
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (07) : 2387 - 2394
  • [45] Quality of Life in Platinum-Sensitive Recurrent Ovarian Cancer: Chemotherapy Versus Surgery Plus Chemotherapy
    Francesco Plotti
    Giuseppe Scaletta
    Alessia Aloisi
    Daniela Luvero
    Stella Capriglione
    Andrea Miranda
    Roberto Montera
    Carlo De Cicco Nardone
    Corrado Terranova
    Roberto Angioli
    Annals of Surgical Oncology, 2015, 22 : 2387 - 2394
  • [46] Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
    Petrillo, Marco
    Zucchetti, Massimo
    Cianci, Stefano
    Morosi, Lavinia
    Ronsini, Carlo
    Colombo, Andrea
    D'Incalci, Maurizio
    Scambia, Giovanni
    Fagotti, Anna
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (04)
  • [47] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Vassos, Nikolaos
    Foertsch, Thomas
    Aladashvili, Archil
    Hohenberger, Werner
    Croner, Roland S.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [48] Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: A pilot study
    Fagotti, A.
    Paris, B.
    Grimolizzi, F.
    Fanfani, F.
    Vizzielli, G.
    Naldini, A.
    Scambia, G.
    GYNECOLOGIC ONCOLOGY, 2009, 113 (03) : 335 - 340
  • [49] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Nikolaos Vassos
    Thomas Förtsch
    Archil Aladashvili
    Werner Hohenberger
    Roland S. Croner
    World Journal of Surgical Oncology, 14
  • [50] Survival impact of secondary cytoreductive surgery for platinum-sensitive relapsed serous ovarian cancer.
    Liu, Jingjing
    Wan, Xiaoyun
    Shen, Yuanming
    Qian, Xueqian
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)